Page 16 - Q1 2024 EN
P. 16

AL MAZAYA HOLDING COMPANY K.S.C.P. AND ITS SUBSIDIARIES
            NOTES TO INTERIM CONSOLIDATED FINANCIAL INFORMATION (UNAUDITED)
            MARCH 31, 2024
            (All amounts are in Kuwaiti Dinars)

               The assets and liabilities as at the date of losing control as follows:

                                                                                                 MedCell
                                                                                                  Medical
                                                                                                   Company
                 Assets:
                  Cash on hand and at banks                                                          140,560
                  Accounts receivable and other debit balances                                       101,560
                  Inventory                                                                           37,314
                  Investment in an associate                                                         272,400
                  Plant and equipment                                                              1,668,353
                  Total assets                                                                     2,220,187
                 Liabilities:
                  Accounts payable and other credit balances                                         484,631
                  Lease liabilities                                                                  470,437
                  Due to related parties                                                             235,529
                  Provision for end of services indemnity                                             73,665
                  Total liabilities                                                                1,264,262
                   Net assets                                                                        955,925
                  Adjustments                                                                         14,112
                                                                                                     970,037
                  Group ownership %                                                                50%
                  Carrying value                                                                     484,048

               The associate’s financial statements summarized as follows:

               Consolidated financial position summarized as follows:

                                                                                                 March 31,
                                                                                                     2024
                                                                                                  (Unaudited)
                  Assets                                                                           2,254,086
                  Liabilities                                                                      1,382,892
                  Equity                                                                             871,194
                  Group ownership %                                                                50%
                  Carrying value                                                                     434,726

               Consolidated statement of profit or loss and other comprehensive income summarized as follows:

                                                                                                For the three
                                                                                               months ended
                                                                                                  March 31,
                                                                                                    2024
                                                                                                 (Unaudited)
                  Revenues                                                                           771,039
                  Loss for the period                                                                (84,729)
                  Share of results from associates                                                   (42,280)









                                                            13
   11   12   13   14   15   16   17   18   19   20   21